Loading...
Please wait, while we are loading the content...
Similar Documents
Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty
| Content Provider | MDPI |
|---|---|
| Author | Hsu, Allen Herng Shouh Yen, Chun-Hsien Kuo, Feng-Chih Wu, Cheng-Ta Huang, Tsan-Wen Cheng, Juei-Tang Lee, Mel S. |
| Copyright Year | 2022 |
| Description | The administration of zoledronic acid (ZA) to patients who received cementless total hip arthroplasty (THA) has been reported to reduce bone turnover markers (BTMs) and increase bone mineral density (BMD). The effects of two-dose ZA versus placebo on cementless THA patients were analyzed in this five-year extension study. Alkaline phosphatase (ALP), osteocalcin (OC), procollagen 1 intact N-terminal propeptide (P1NP), serum calcium, renal function, radiological findings, and functional outcomes were compared in 49 patients, and the periprosthetic BMD of seven Gruen zones were compared in 19 patients. All the patients had normal renal function and calcium levels at their final follow-up. The mean ALP level in the ZA group was significantly lower at the fifth year, mean OC levels were significantly lower at the second and fifth year, and mean P1NP levels were significantly lower from 6 weeks to 5 years as compared with the control group. Fifth-year BMD levels were not found to be different between the ZA and control groups. The BMD Change Ratios in the ZA group were significantly increased in Gruen zone 6 at 1, 2, and 5 years. Our study results suggest that short-term ZA treatment with a subsequent 4-year drug holiday may inhibit serum BTMs and provide periprosthetic bone preservation at five years without adverse events. |
| Starting Page | 420 |
| e-ISSN | 14248247 |
| DOI | 10.3390/ph15040420 |
| Journal | Pharmaceuticals |
| Issue Number | 4 |
| Volume Number | 15 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2022-03-30 |
| Access Restriction | Open |
| Subject Keyword | Pharmaceuticals Orthopedics Bisphosphonate Zoledronic Acid Total Hip Arthroplasty Bone Mineral Density Bone Turnover Marker |
| Content Type | Text |
| Resource Type | Article |
